Anzeige
Mehr »
Donnerstag, 23.10.2025 - Börsentäglich über 12.000 News
Das Comeback des Goldrauschs - diesmal ausgelöst durch eine Währungskrise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B7QK | ISIN: GB0034330679 | Ticker-Symbol: DWV
Frankfurt
22.10.25 | 21:49
0,029 Euro
-12,31 % -0,004
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
ANGLE PLC Chart 1 Jahr
5-Tage-Chart
ANGLE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0290,03122.10.

Aktuelle News zur ANGLE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.10.IN BRIEF: Angle names Peter Collins as interim CEO1
16.10.Angle Appoints Peter Collins As Interim CEO1
16.10.ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor167GUILFORD, SURREY / ACCESS Newswire / October 16, 2025 / ANGLE plc (to be renamed CelLBxHealth plc) (AIM:AGL)(OTCQX:ANPCY), a world-leading circulating tumour cell (CTC) intelligence company with tests...
► Artikel lesen
08.10.Angle touts planned name and strategy change, Groen turns executive11
08.10.Angle PLC Announces Strategy Update146Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth plcDr. Jan Groen, the current Non-Executive Chairman...
► Artikel lesen
29.09.Angle PLC Announces Presentation of Data on Glioblastoma170CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the 7th ACTC meeting GUILDFORD, SURREY / ACCESS...
► Artikel lesen
29.09.Angle: Presentation of Data on Glioblastoma-
12.09.IN BRIEF: Angle CEO and finance lead step down after shareholder talks1
ANGLE Aktie jetzt für 0€ handeln
12.09.Angle founder and CEO steps down after shareholder backlash1
12.09.Angle CEO and finance director resign2
12.09.Angle PLC Announces Board Changes296GUILDFORD, SURREY / ACCESS Newswire / September 12, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in...
► Artikel lesen
09.09.Shares in Angle tumble on gloomy outlook2
09.09.Angle H1 Pre-tax Loss Widens, Lowers FY25 Guidance; Stock Down5
09.09.Angle shares suffer as interim loss widens amid weaker revenue3
09.09.Angle PLC Announces Interim Results201ANGLE plc("ANGLE" or "the Company")Interim Results for the six months ended 30 June 2025COMMERCIALISATION PROGRESSED ACROSS MULTIPLE FRONTS DESPITE REVENUE PRESSURE FROM ADVERSE MARKET CONDITIONSLarge...
► Artikel lesen
09.09.Angle PLC Announces Change of Adviser144APPOINTMENT OF NOMINATED ADVISER AND SOLE BROKER GUILDFORD, SURREY / ACCESS Newswire / September 9, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating...
► Artikel lesen
05.09.Angle PLC Announces Notice of Results242ANGLE plc ("the Company") Notice of Interim Results and Webcast GUILDFORD, SURREY / ACCESS Newswire / September 5, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with...
► Artikel lesen
05.09.ANGLE plc legt Halbjahresergebnisse am 9. September vor2
05.09.LONDON - ANGLE plc to release interim results on September 92
20.08.Angle teams up with Myriad Genetics on cancer patient blood testing1
Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1